CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.
暂无分享,去创建一个
H. Tilg | O. Majdic | H. Stockinger | C. Huber | R. Margreiter | B. Eibl | D. Niederwieser | W. Aulitzky | D. Nachbaur | H. Schwaighofer | G. Oberhuber | G. Aichinger | P. König | C. Gattringer | A. M. Födinger
[1] F. Emmrich,et al. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process. , 1995, Transplantation proceedings.
[2] A. O'Rourke,et al. The roles of CD8 in cytotoxic T lymphocyte function. , 1993, Immunology today.
[3] C. Maroun,et al. Distinct roles for CD4 and CD8 as co-receptors in antigen receptor signalling. , 1993, Immunology today.
[4] K. Wood,et al. THE ASSESSMENT OF TRANSPLANTATION TOLERANCE INDUCED BY ANTI‐CD4 MONOCLONAL ANTIBODY IN THE MURINE MODEL1 , 1993, Transplantation.
[5] H. Volk,et al. INDUCTION OF LONG‐TERM SURVIVAL OF RAT SKIN ALLOGRAFTS BY A NOVEL, HIGHLY EFFICIENT ANTI‐CD4 MONOCLONAL ANTIBODY , 1992, Transplantation.
[6] G. Opelz. Collaborative Transplant Study--10-year report. , 1992, Transplantation proceedings.
[7] J. Madsen,et al. INDUCTION OF TRANSPLANTATION TOLERANCE IN ADULTS USING DONOR ANTIGEN AND ANTI‐CD4 MONOCLONAL ANTIBODY , 1992, Transplantation.
[8] F. Emmrich,et al. Anti-CD4 therapy of acute rejection in long-term renal allograft recipients , 1991, The Lancet.
[9] J. Chapman,et al. Survival of DNA HLA-DR typed and matched cadaver kidney transplants , 1991, The Lancet.
[10] T. Sablinski,et al. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. , 1991, Transplantation.
[11] Thomas P. J. Garrett,et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.
[12] V. Starnes,et al. INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI‐CD4 MONOCLONAL ANTIBODY THERAPY , 1990, Transplantation.
[13] M. Giral,et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. , 1990, The New England journal of medicine.
[14] R. Perlmutter,et al. Interaction of the unique N-terminal region of tyrosine kinase p56 lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs , 1990, Cell.
[15] T. Waldmann,et al. Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] E. Reinherz,et al. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding , 1989, Nature.
[17] C. Fathman,et al. CARDIAC ALLOGRAFT PROLONGATION IN MICE TREATED WITH COMBINED POSTTRANSPLANTATION TOTAL‐LYMPHOID IRRADIATION AND ANTI‐L3T4 ANTIBODY THERAPY , 1989, Transplantation.
[18] L. Samelson,et al. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck , 1989, Nature.
[19] H. Waldmann,et al. Manipulation of T-cell responses with monoclonal antibodies. , 1989, Annual review of immunology.
[20] B. Roser,et al. STRATEGIES OF MONOCLONAL ANTIBODY THERAPY THAT INDUCE PERMANENT TOLERANCE OF ORGAN TRANSPLANTS , 1988, Transplantation.
[21] D. Kaufman,et al. USE OF ANTI‐L3T4 AND ANTI‐Ia TREATMENTS FOR PROLONGATION OF XENOGENEIC ISLET TRANSPLANTS , 1988, Transplantation.
[22] B. Seed,et al. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4 , 1988, Cell.
[23] C. Rudd,et al. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Fathman,et al. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. , 1988, Science.
[25] D. Niederwieser,et al. IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. , 1988, Journal of immunology.
[26] W. Knapp,et al. MONOCLONAL ANTI-CD4 IN ARTHRITIS , 1987, The Lancet.
[27] J. Madsen,et al. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. , 1987, Transplantation.
[28] J. Strominger,et al. Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.
[29] C. Fathman,et al. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. , 1987, Science.
[30] W. Seaman,et al. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.
[31] R. Klausner,et al. Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor , 1986, Cell.
[32] C. Fathman,et al. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 , 1986, The Journal of experimental medicine.
[33] O. Majdic,et al. Analysis of CD3-antibody-mediated inhibition of T-cell activation. , 1986, Cellular immunology.
[34] H. Waldmann,et al. Induction of tolerance by monoclonal antibody therapy , 1986, Nature.
[35] I. Bernstein,et al. Leukocyte Typing II , 1986, Springer New York.
[36] L. Chess,et al. Perturbation of the T4 molecule transmits a negative signal to T cells , 1985, The Journal of experimental medicine.
[37] W. Seaman,et al. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. , 1985, Journal of immunology.
[38] S. Sriram,et al. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 , 1985, The Journal of experimental medicine.
[39] P. Neuhaus,et al. OKT4 AND OKT4A ANTIBODY TREATMENT AS IMMUNOSUPPRESSION FOR KIDNEY TRANSPLANTATION IN RHESUS MONKEYS , 1985, Transplantation.
[40] M. Waldor,et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. , 1985, Science.
[41] R. Rubin,et al. EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTION , 1984, Transplantation.
[42] L. Chess,et al. The T4 surface antigen is involved in the induction of helper function. , 1984, Journal of immunology.
[43] G. Danovitch,et al. Renal transplantation update. , 1984, Annals of internal medicine.
[44] P. Marrack,et al. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. , 1983, Journal of immunology.
[45] K. A. Wall,et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.
[46] W. Biddison,et al. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens. , 1983, Diagnostic immunology.
[47] R. Colvin,et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. , 1981, The New England journal of medicine.
[48] R. Filo,et al. THERAPY OF ACUTE CADAVERIC RENAL ALLOGRAFT REJECTION WITH ADJUNCTIVE ANTITHYMOCYTE GLOBULIN , 1980, Transplantation.
[49] C. Huber,et al. Linear density gradient separation of human lymphocyte subsets , 1977, European journal of immunology.